Drug General Information
Drug ID	D0C6VV
Former ID	DCL001125
Drug Name	Prolarix
Synonyms	Prolarix (TN)
Drug Type	Small molecular drug
Indication	Cancer [ICD9: 140-229; ICD10:C00-C96]		Phase 2	[522427]
Therapeutic Class	Anticancer Agents
Company	Protherics
Structure		Download 2D MOL 3D MOL
Formula	C8H11N3O2
Canonical SMILES	C1C=CN(C=C1C(=O)N)CC(=O)N
InChI	1S/C8H11N3O2/c9-7(12)5-11-3-1-2-6(4-11)8(10)13/h1,3-4H,2,5H2,(H2,9,12)(H2,10,13)
InChIKey	WEJRSYKFMCUCRQ-UHFFFAOYSA-N
PubChem Compound ID	403128
PubChem Substance ID	534303, 11444956, 11566832, 15147337, 35564134, 51427958, 103088956, 103155631, 104591224, 117569620, 129569544, 134338866, 135252704, 137249657, 160677330, 162890133, 198979262, 232258944
Target and Pathway
Target(s)	NRH dehydrogenase [quinone] 2	Target Info	Inhibitor	[550543]
References
Ref 522427	ClinicalTrials.gov (NCT00746590) Study of Anti-tumour Effects and Safety of Prolarix in Hepatocellular Carcinoma. U.S. National Institutes of Health.
Ref 550543	CenterWatch. Drugs in Clinical Trials Database. CenterWatch. 2008.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.